Drug Database
Back to search

France· FR:66152222

PAMIDRONATE DE SODIUM HOSPIRA 3 mg/mL, solution à diluer pour perfusion

A medicinal product containing pamidronate de sodium, registered in France by PFIZER HOLDING FRANCE.

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedPAMIDRONATE DE SODIUM HOSPIRA 3 mg/mL…ATC—REGISTER NO.FR:66152222PACKS LISTED2CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about pamidronate de sodiumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
PAMIDRONATE DE SODIUM
Manufacturer
PFIZER HOLDING FRANCE
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

  • cip13
    3400938169669
    5 flacon(s) en verre de 5 ml
  • cip13
    3400938169720
    1 flacon(s) en verre de 10 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Pamidronate de sodium in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pamidronate de sodium products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Portugal · Pamidronato Hikma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f076836a-2716-45a4-992d-16957e71dac7
GET /v1/drugs/f076836a-2716-45a4-992d-16957e71dac7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "66152222",
  "date_amm": "2002-07-22",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "PAMIDRONATE DE SODIUM",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution à diluer pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about pamidronate de sodium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console